Alkermes Moving to Waltham
Luke Timmerman4/22/09
Alkermes, the Cambridge, MA-based developer of anti-addiction drugs, said today it has signed a lease to move its headquarters to Waltham, MA. The company (NASDAQ: ALKS), which has more than 600 employees, plans to complete the move in early 2010. The move is supposed to save the company $8 million a year starting in fiscal 2011.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
